|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
| CP1
|
| 12/21/2004
|
| 12/22/2004
|
| Drug Industry
|
| Valeant Pharmaceuticals
International
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
| Signature:
|
| Dr. Kim D. Lamon,Dr. Grag J.
Kricorian
|
|
|
| ACK1
|
| 12/21/2004
|
| 12/21/2004
|
| Federal Government
|
| HFA-305 to Valeant
Pharmaceuticals International
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
| LET1
|
| 06/17/2005
|
| 06/17/2005
|
| Federal Government
|
| HFD-5 to Valeant Pharmaceuticals
International
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Jane A Axelrad
|
|
|
| C1
|
| 09/16/2005
|
| 09/16/2005
|
| Private Industry
|
| Rothwell Figg Ernst
& Manbeck PC
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Stephen Lieberman
|
|
|
| LET2
|
| 10/07/2005
|
| 10/07/2005
|
| Drug Industry
|
| Valeant Pharmaceuticals
International
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| Brian R McCormick
|
|
|
| RC1
|
| 10/21/2005
|
| 10/21/2005
|
| Drug Industry
|
| Valeant Pharmaceuticals
International
|
|
|
|
|
|
|
| pdf
Tabs
|
|
|
|
| Signature:
|
| Kim D. Lamon, M.D., PhD and
Greg J
|
|
|
| C2
|
| 01/03/2006
|
| 01/03/2006
|
| Private Industry
|
| Rothwell Figg Ernst
& Manbeck
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
| Signature:
|
| Steven Lieberman
|
|
|
| LET3
|
| 01/13/2006
|
| 01/13/2006
|
| Private Industry
|
| Hogan & Hartson,
LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| David M. Fox
|
|
|
| RC2
|
| 04/03/2006
|
| 04/03/2006
|
| Drug Industry
|
| Valeant Pharmaceuticals
International
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
| Signature:
|
| Greg J. Kricorian, M.D.
|
|
|
| OB1
|
| 04/28/2006
|
| 04/24/2006
|
| Individual Consumer
|
| D. Lowe
|
|
|
|
|
|
|
|
|
|
|
|
|
| C3
|
| 05/05/2006
|
| 05/05/2006
|
| Private Industry
|
| Rothwell Figg Ernst
& Manbeck
|
|
|
|
|
|
|
| pdf
Appendices
|
|
|
|
| Signature:
|
| Steven Lieberman
|
|
|
| LET4
|
| 05/31/2006
|
| 05/31/2006
|
| Drug Industry
|
| Valeant Pharmaceuticals
International
|
|
|
|
|
|
|
| pdf
|
|
|
|
| Signature:
|
| David M. Fox
| |
|
| RC3
|
| 07/13/2006
|
| 07/13/2006
|
| Drug Industry
|
| Valeant Pharmaceuticals
International
|
|
|
|
|
|
|
| pdf
Tab
1
|
|
|
|
| Signature:
|
| Greg J. Kricorian, M.D.
| |